Ionis Pharmaceuticals: Piper Sandler cuts target price to $60 from $87
IONS•Piper Sandler cut its target price on Ionis Pharmaceuticals to $60 from $87.
Related News
Palisade Bio: Piper Sandler cuts target price to $16 from $25
PALI•
Western Union announces termination of agreement to acquire Intermex
IMXI•
NRG Energy: CIBC cuts target price to $154 from $159
NRG•
PepGen Inc.: Leerink Partners raises target price to $16 from $10
PEPG•
IELTS co-owner IDP jumps 16% after Blackstone sweetens bid again
BX•